- Application under evaluation
- CHMP opinion
- European Commission decision
Overview
The marketing authorisation for PANTOLOC Control has been withdrawn at the request of the marketing-authorisation holder.
Pantoloc Control : EPAR - Summary for the public
English (EN) (250.71 KB - PDF)
български (BG) (340.44 KB - PDF)
español (ES) (252.29 KB - PDF)
čeština (CS) (326.49 KB - PDF)
dansk (DA) (251.47 KB - PDF)
Deutsch (DE) (254.12 KB - PDF)
eesti keel (ET) (250.74 KB - PDF)
ελληνικά (EL) (341.93 KB - PDF)
français (FR) (254.06 KB - PDF)
italiano (IT) (274.87 KB - PDF)
latviešu valoda (LV) (301.98 KB - PDF)
lietuvių kalba (LT) (299.44 KB - PDF)
magyar (HU) (297.85 KB - PDF)
Malti (MT) (304.54 KB - PDF)
Nederlands (NL) (252.26 KB - PDF)
polski (PL) (324.73 KB - PDF)
português (PT) (252.86 KB - PDF)
română (RO) (300.23 KB - PDF)
slovenčina (SK) (324.89 KB - PDF)
slovenščina (SL) (314.03 KB - PDF)
Suomi (FI) (251.1 KB - PDF)
svenska (SV) (274.56 KB - PDF)
Product information
Pantoloc Control : EPAR - Product Information
English (EN) (600.2 KB - PDF)
български (BG) (1.07 MB - PDF)
español (ES) (583.66 KB - PDF)
čeština (CS) (875.66 KB - PDF)
dansk (DA) (613.28 KB - PDF)
Deutsch (DE) (652.38 KB - PDF)
eesti keel (ET) (617.31 KB - PDF)
ελληνικά (EL) (1.02 MB - PDF)
français (FR) (612.45 KB - PDF)
hrvatski (HR) (630.71 KB - PDF)
íslenska (IS) (544.96 KB - PDF)
italiano (IT) (633.07 KB - PDF)
latviešu valoda (LV) (888.24 KB - PDF)
lietuvių kalba (LT) (652.93 KB - PDF)
magyar (HU) (880.31 KB - PDF)
Malti (MT) (920.18 KB - PDF)
Nederlands (NL) (656.74 KB - PDF)
norsk (NO) (570.97 KB - PDF)
polski (PL) (903.95 KB - PDF)
português (PT) (545.3 KB - PDF)
română (RO) (622.05 KB - PDF)
slovenčina (SK) (893.89 KB - PDF)
slovenščina (SL) (862.7 KB - PDF)
Suomi (FI) (544.55 KB - PDF)
svenska (SV) (604.01 KB - PDF)
This medicine’s product information is available in all official EU languages.
Select 'available languages' to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
Pantoloc Control : EPAR - All Authorised presentations
English (EN) (172.49 KB - PDF)
български (BG) (253.21 KB - PDF)
español (ES) (173.2 KB - PDF)
čeština (CS) (208.38 KB - PDF)
dansk (DA) (173.02 KB - PDF)
Deutsch (DE) (172.99 KB - PDF)
eesti keel (ET) (173.36 KB - PDF)
ελληνικά (EL) (250.46 KB - PDF)
français (FR) (173.04 KB - PDF)
hrvatski (HR) (198.63 KB - PDF)
íslenska (IS) (181.13 KB - PDF)
italiano (IT) (172.91 KB - PDF)
latviešu valoda (LV) (247.6 KB - PDF)
lietuvių kalba (LT) (242.14 KB - PDF)
magyar (HU) (247.53 KB - PDF)
Malti (MT) (245.34 KB - PDF)
Nederlands (NL) (172.36 KB - PDF)
norsk (NO) (181.03 KB - PDF)
polski (PL) (246.38 KB - PDF)
português (PT) (173.72 KB - PDF)
română (RO) (236.59 KB - PDF)
slovenčina (SK) (209.5 KB - PDF)
slovenščina (SL) (179.91 KB - PDF)
Suomi (FI) (172.58 KB - PDF)
svenska (SV) (173.01 KB - PDF)
Product details
- Name of medicine
- Pantoloc Control
- Active substance
- pantoprazole
- International non-proprietary name (INN) or common name
- pantoprazole
- Therapeutic area (MeSH)
- Gastroesophageal Reflux
- Anatomical therapeutic chemical (ATC) code
- A02BC02
Pharmacotherapeutic group
Proton pump inhibitorsTherapeutic indication
Short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.
Authorisation details
- EMA product number
- EMEA/H/C/001100
- Marketing authorisation holder
- Takeda GmbH
Byk-Gulden-Strasse 2
D-78467 Konstanz
Germany - Opinion adopted
- 19/02/2009
- Marketing authorisation issued
- 11/06/2009
- Revision
- 18
Assessment history
Pantoloc Control : EPAR - Procedural steps taken and scientific information after authorisation
English (EN) (473.19 KB - PDF)
Pantoloc Control-H-C-PSUSA-00002285-201708 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
English (EN) (274.61 KB - PDF)
Related information
Public statement on PANTOLOC Control : Withdrawal of the marketing authorisation in the European Union
English (EN) (291.48 KB - PDF)